O-I Glass (OI) 10-Q 30 Apr 14 2014 Q1 Quarterly report Financial data

Document_and_Entity_Informatio

Document and Entity Information	3 Months Ended
	Mar. 31, 2014
Document and Entity Information	'
Entity Registrant Name	'OWENS ILLINOIS INC /DE/
Entity Central Index Key	'0000812074
Document Type	'10-Q
Document Period End Date	31-Mar-14
Amendment Flag	'false
Current Fiscal Year End Date	'--12-31
Entity Current Reporting Status	'Yes
Entity Filer Category	'Large Accelerated Filer
Entity Common Stock, Shares Outstanding	165,074,114
Document Fiscal Year Focus	'2014
Document Fiscal Period Focus	'Q1

CONDENSED_CONSOLIDATED_RESULTS

CONDENSED CONSOLIDATED RESULTS OF OPERATIONS (USD $)	3 Months Ended
In Millions, except Share data in Thousands, unless otherwise specified	Mar. 31, 2014	Mar. 31, 2013
CONDENSED CONSOLIDATED RESULTS OF OPERATIONS	'	'
Net sales	$1,639	$1,641
Cost of goods sold	-1,318	-1,322
Gross profit	321	319
Selling and administrative expense	-133	-129
Research, development and engineering expense	-15	-15
Interest expense, net	-54	-68
Equity earnings	16	17
Other expense, net	-1	-7
Earnings from continuing operations before income taxes	134	117
Provision for income taxes	-27	-33
Earnings from continuing operations	107	84
Loss from discontinued operations	-1	-10
Net earnings	106	74
Net earnings attributable to noncontrolling interests	-5	-5
Net earnings attributable to the Company	101	69
Amounts attributable to the Company:	'	'
Earnings from continuing operations	102	79
Loss from discontinued operations	-1	-10
Net earnings	$101	$69
Basic earnings per share:	'	'
Earnings from continuing operations	$0.62	$0.48
Loss from discontinued operations	($0.01)	($0.06)
Net earnings	$0.61	$0.42
Weighted average shares outstanding	164,760	164,069
Diluted earnings per share:	'	'
Earnings from continuing operations	$0.62	$0.48
Loss from discontinued operations	($0.01)	($0.06)
Net earnings	$0.61	$0.42
Weighted average shares outstanding	166,165	165,501

CONDENSED_CONSOLIDATED_COMPREH

CONDENSED CONSOLIDATED COMPREHENSIVE INCOME (USD $)	3 Months Ended
In Millions, unless otherwise specified	Mar. 31, 2014	Mar. 31, 2013
CONDENSED CONSOLIDATED COMPREHENSIVE INCOME	'	'
Net earnings	$106	$74
Other comprehensive income:	'	'
Foreign currency translation adjustments	32	-32
Pension and other postretirement benefit adjustments, net of tax	23	45
Change in fair value of derivative instruments	1	4
Other comprehensive income	56	17
Total comprehensive income	162	91
Comprehensive income attributable to noncontrolling interests	-2	-1
Comprehensive income attributable to the Company	$160	$90

CONDENSED_CONSOLIDATED_BALANCE

CONDENSED CONSOLIDATED BALANCE SHEETS (USD $)	Mar. 31, 2014	Dec. 31, 2013	Mar. 31, 2013	Dec. 31, 2012
In Millions, unless otherwise specified
Current assets:	'	'	'	'
Cash and cash equivalents	$201	$383	$359	'
Receivables	1,078	943	1,047	'
Inventories	1,204	1,117	1,178	'
Prepaid expenses	94	107	99	'
Total current assets	2,577	2,550	2,683	'
Property, plant and equipment, net	2,634	2,632	2,680	'
Goodwill	2,059	2,059	2,048	'
Other assets	1,218	1,178	1,106	'
Total assets	8,488	8,419	8,517	'
Current liabilities:	'	'	'	'
Short-term loans and long-term debt due within one year	331	322	347	'
Current portion of asbestos-related liabilities	150	150	155	'
Accounts payable	1,074	1,144	904	'
Other liabilities	527	638	523	'
Total current liabilities	2,082	2,254	1,929	'
Long-term debt	3,371	3,245	3,550	'
Asbestos-related liabilities	283	298	289	'
Other long-term liabilities	992	1,019	1,594	'
Share owners' equity	1,760	1,603	1,155	1,055
Total liabilities and share owners' equity	$8,488	$8,419	$8,517	'

CONDENSED_CONSOLIDATED_CASH_FL

CONDENSED CONSOLIDATED CASH FLOWS (USD $)	3 Months Ended
In Millions, unless otherwise specified	Mar. 31, 2014		Mar. 31, 2013
Cash flows from operating activities:	'		'
Net earnings	$106		$74
Loss from discontinued operations	1		10
Non-cash charges	'		'
Depreciation and amortization	111		107
Pension expense	15		26
Restructuring, asset impairment and related charges	'		10
Cash payments	'		'
Pension contributions	-5		-7
Asbestos-related payments	-15		-17
Cash paid for restructuring activities	-21		-34
Change in components of working capital	-352		-301
Other, net (a)	-42	[1]	-2	[1]
Cash utilized in continuing operating activities	-202		-134
Cash utilized in discontinued operating activities	-1		-2
Total cash utilized in operating activities	-203		-136
Cash flows from investing activities:	'		'
Additions to property, plant and equipment	-108		-94
Other, net	13		'
Cash utilized in investing activities	-95		-94
Cash flows from financing activities:	'		'
Changes in borrowings, net	136		160
Issuance of common stock	4		4
Distributions to noncontrolling interests	-19		'
Other, net	1		-5
Cash provided by financing activities	122		159
Effect of exchange rate fluctuations on cash	-6		-1
Decrease in cash	-182		-72
Cash at beginning of period	383		431
Cash at end of period	$201		$359
[1]	(a) Other, net includes other non cash charges plus other changes in non-current assets and liabilities.

Segment_Information

Segment Information	3 Months Ended
	Mar. 31, 2014
Segment Information	'
Segment Information	'
	1.              Segment Information
	The Company has four reportable segments based on its geographic locations:  Europe, North America, South America and Asia Pacific.  These four segments are aligned with the Company’s internal approach to managing, reporting, and evaluating performance of its global glass operations.  Certain assets and activities not directly related to one of the regions or to glass manufacturing are reported with Retained corporate costs and other.  These include licensing, equipment sales, global engineering, and non-glass equity investments.  Retained corporate costs and other also includes certain headquarters administrative and facilities costs and certain incentive compensation and other benefit plan costs that are global in nature and are not allocable to the reportable segments.
	The Company’s measure of profit for its reportable segments is segment operating profit, which consists of consolidated earnings from continuing operations before interest income, interest expense, and provision for income taxes and excludes amounts related to certain items that management considers not representative of ongoing operations as well as certain retained corporate costs.  The Company’s management uses segment operating profit, in combination with net sales and selected cash flow information, to evaluate performance and to allocate resources.  Segment operating profit for reportable segments includes an allocation of some corporate expenses based on both a percentage of sales and direct billings based on the costs of specific services provided.
	Financial information for the three-month periods ended March 31, 2014 and 2013 regarding the Company’s reportable segments is as follows:
		2014			2013
	Net sales:
	Europe	$	706		$	650
	North America	485			469
	South America	239			269
	Asia Pacific	203			247
	Reportable segment totals	1,633			1,635
	Other	6			6
	Net sales	$	1,639		$	1,641
		2014			2013
	Segment operating profit:
	Europe	$	87		$	59
	North America	65			74
	South America	41			53
	Asia Pacific	25			40
	Reportable segment totals	218			226
	Items excluded from segment operating profit:
	Retained corporate costs and other	(30		)	(31		)
	Restructuring, asset impairment and related charges				(10		)
	Interest expense, net	(54		)	(68		)
	Earnings from continuing operations before income taxes	$	134		$	117
	Financial information regarding the Company’s total assets is as follows:
		March 31,			December 31,			March 31,
		2014			2013			2013
	Total assets:
	Europe	$	3,585		$	3,509		$	3,263
	North America	2,055			1,995			2,030
	South America	1,453			1,467			1,638
	Asia Pacific	1,142			1,150			1,294
	Reportable segment totals	8,235			8,121			8,225
	Other	253			298			292
	Consolidated totals	$	8,488		$	8,419		$	8,517

Receivables

Receivables	3 Months Ended
	Mar. 31, 2014
Receivables	'
Receivables	'
	2.  Receivables
	Receivables consist of the following:
		March 31,		December 31,		March 31,
		2014		2013		2013
	Trade accounts receivable	$	911	$	757	$	903
	Less: allowances for doubtful accounts and discounts	39		39		41
	Net trade receivables	872		718		862
	Other receivables	206		225		185
		$	1,078	$	943	$	1,047
	The Company uses various factoring programs to sell certain receivables to financial institutions as part of managing its cash flows. The amount of receivables sold by the Company was $129 million, $192 million, and $116 million at March 31, 2014, December 31, 2013, and March 31, 2013, respectively. The Company has no continuing involvement with the sold receivables.

Inventories

Inventories	3 Months Ended
	Mar. 31, 2014
Inventories	'
Inventories	'
	3.  Inventories
	Major classes of inventory are as follows:
		March 31,		December 31,		March 31,
		2014		2013		2013
	Finished goods	$	1,037	$	958	$	1,014
	Raw materials	121		113		124
	Operating supplies	46		46		40
		$	1,204	$	1,117	$	1,178

Derivative_Instruments

Derivative Instruments	3 Months Ended
	Mar. 31, 2014
Derivative Instruments	'
Derivative Instruments	'
	4. Derivative Instruments
	The Company has certain derivative assets and liabilities which consist of natural gas forwards and foreign exchange option and forward contracts.  The Company uses an income approach to valuing these contracts.  Natural gas forward rates and foreign exchange rates are the significant inputs into the valuation models.  These inputs are observable in active markets over the terms of the instruments the Company holds, and accordingly, the Company classifies its derivative assets and liabilities as Level 2 in the hierarchy.  The Company also evaluates counterparty risk in determining fair values.
	Commodity Futures Contracts Designated as Cash Flow Hedges
	The significant majority of the Company’s sales volume in North America is tied to customer contracts that contain provisions that pass the price of natural gas to the customer.  In certain of these contracts, the customer has the option of fixing the natural gas price component for a specified period of time. When the customer exercises that option the Company enters into commodity futures contracts for the related natural gas requirements, in order to limit the effects of fluctuations in the future market price paid for natural gas and the related volatility in cash flows.  At March 31, 2014 and 2013, the Company had entered into commodity futures contracts covering approximately 4,400,000 MM BTUs and 6,200,000 MM BTUs, respectively, primarily related to customer requests to lock the price of natural gas.
	The Company accounts for these futures contracts as cash flow hedges and recognizes them on the balance sheet at fair value. The effective portion of changes in the fair value of a derivative that is designated as, and meets the required criteria for, a cash flow hedge is recorded in the Accumulated Other Comprehensive Income component of share owners’ equity (“OCI”) and reclassified into earnings in the same period or periods during which the underlying hedged item affects earnings. An unrecognized gain of $2 million at both March 31, 2014 and 2013 related to the commodity futures contracts was included in Accumulated OCI, and will be reclassified into earnings over the next twelve to twenty-four months.  Any material portion of the change in the fair value of a derivative designated as a cash flow hedge that is deemed to be ineffective is recognized in current earnings.  The ineffectiveness related to these natural gas hedges for the three months ended March 31, 2014 and 2013 was not material.
	The effect of the commodity futures contracts on the results of operations for the three months ended March 31, 2014 and 2013 is as follows:
							Amount of Gain (Loss)
	Amount of Gain						Reclassified from
	Recognized in OCI on						Accumulated OCI into Income
	Commodity Futures Contracts						(reported in Cost of goods sold)
	(Effective Portion)						(Effective Portion)
	2014			2013			2014			2013
	$	2		$	3		$	1		$	(1	)
	Forward Exchange Contracts not Designated as Hedging Instruments
	The Company’s subsidiaries may enter into short-term forward exchange or option agreements to purchase foreign currencies at set rates in the future. These agreements are used to limit exposure to fluctuations in foreign currency exchange rates for significant planned purchases of fixed assets or commodities that are denominated in currencies other than the subsidiaries’ functional currency. Subsidiaries may also use forward exchange agreements to offset the foreign currency risk for receivables and payables, including intercompany receivables and payables, not denominated in, or indexed to, their functional currencies. The Company records these short-term forward exchange agreements on the balance sheet at fair value and changes in the fair value are recognized in current earnings.
	At March 31, 2014 and 2013, various subsidiaries of the Company had outstanding forward exchange and option agreements denominated in various currencies covering the equivalent of approximately $670 million and $900 million, respectively, related primarily to intercompany transactions and loans.
	The effect of the forward exchange contracts on the results of operations for the three months ended March 31, 2014 and 2013 is as follows:
			Amount of Loss
	Location of Gain (Loss)		Recognized in Income on
	Recognized in Income on		Forward Exchange Contracts
	Forward Exchange Contracts		2014			2013
	Other expense, net		$	(1	)	$	(3	)
	Balance Sheet Classification
	The Company records the fair values of derivative financial instruments on the balance sheet as follows: (a) receivables if the instrument has a positive fair value and maturity within one year, (b) other assets if the instrument has a positive fair value and maturity after one year, (c) other liabilities (current) if the instrument has a negative fair value and maturity within one year, and (d) other long-term liabilities if the instrument has a negative fair value and maturity after one year.  The following table shows the amount and classification (as noted above) of the Company’s derivatives:
			Balance		Fair Value
			Sheet		March 31,			December 31,			March 31,
			Location		2014			2013			2013
	Asset Derivatives:
	Derivatives designated as hedging instruments:
	Commodity futures contracts		a		$	2		$	1		$	2
	Derivatives not designated as hedging instruments:
	Foreign exchange contracts		a		4			3			3
	Foreign exchange contracts		c		3						1
	Total derivatives not designated as hedging instruments				7			3			4
	Total asset derivatives				$	9		$	4		$	6
	Liability Derivatives:
	Derivatives not designated as hedging instruments:
	Foreign exchange contracts		c		$	10		$	7		$	8
	Total liability derivatives				$	10		$	7		$	8

Restructuring_Accruals

Restructuring Accruals	3 Months Ended
	Mar. 31, 2014
Restructuring Accruals	'
Restructuring Accruals	'
	5.  Restructuring Accruals
	Selected information related to the restructuring accruals for the first three months of 2014 and 2013 is as follows:
		European			Asia Pacific			Other			Total
		Asset			Restructuring			Restructuring			Restructuring
		Optimization						Actions
	Balance at January 1, 2014	$	30		$	20		$	64		$	114
	Net cash paid, principally severance and related benefits	(2		)	(4		)	(15		)	(21		)
	Other, including foreign exchange translation	(1		)	(4		)	(3		)	(8		)
	Balance at March 31, 2014	$	27		$	12		$	46		$	85
	Balance at January 1, 2013	$	53		$	6		$	64		$	123
	First quarter 2013 charges	7			2			1			10
	Write-down of assets to net realizable value	(2		)							(2		)
	Net cash paid, principally severance and related benefits	(20		)	(4		)	(10		)	(34		)
	Other, including foreign exchange translation	(1		)				(1		)	(2		)
	Balance at March 31, 2013	$	37		$	4		$	54		$	95
	The Company’s decisions to curtail selected production capacity have resulted in write downs of certain long-lived assets to the extent their carrying amounts exceeded fair value or fair value less cost to sell.  The Company classified the significant assumptions used to determine the fair value of the impaired assets, which was not material, as Level 3 in the fair value hierarchy as set forth in the general accounting principles for fair value measurements.

Pensions_Benefit_Plans

Pensions Benefit Plans	3 Months Ended
	Mar. 31, 2014
Pensions Benefit Plans	'
Pensions Benefit Plans	'
	6.  Pension Benefit Plans
	The components of the net periodic pension cost for the three months ended March 31, 2014 and 2013 are as follows:
		U.S.						Non-U.S.
		2014			2013			2014			2013
	Service cost	$	6		$	7		$	7		$	8
	Interest cost	27			27			18			17
	Expected asset return	(43		)	(46		)	(22		)	(23		)
	Amortization:
	Actuarial loss	18			28			4			8
	Net periodic pension cost	$	8		$	16		$	7		$	10
	The U.S. pension expense excludes $8 million of special termination benefits that were recorded in discontinued operations in 2013.

Income_Taxes

Income Taxes	3 Months Ended
	Mar. 31, 2014
Income Taxes	'
Income Taxes	'
	7.  Income Taxes
	The Company performs a quarterly review of the annual effective tax rate and makes changes if necessary based on new information or events. The estimated annual effective tax rate is forecasted quarterly using actual historical information and forward-looking estimates. The estimated annual effective tax rate may fluctuate due to changes in forecasted annual operating income; changes in the forecasted mix of earnings by country; changes to the valuation allowance for deferred tax assets (such changes would be recorded discretely in the quarter in which they occur); changes to actual or forecasted permanent book to tax differences (non-deductible expenses); impacts from future tax settlements with state, federal or foreign tax authorities (such changes would be recorded discretely in the quarter in which they occur); or impacts from tax law changes. To the extent such changes impact deferred tax assets/liabilities, these changes would generally be recorded discretely in the quarter in which they occur.  Additionally, the annual effective tax rate differs from the statutory U.S. Federal tax rate of 35% primarily because of valuation allowances in some jurisdictions and varying non-U.S. tax rates.
	In the U.S., the Company has experienced cumulative losses in previous years and has recorded a valuation allowance against its deferred tax assets. The Company’s U.S. operations are in a three-year cumulative income position, but this is not solely determinative of the need for a valuation allowance. The Company considered this factor and all other available positive and negative evidence and concluded that it is still more likely than not that the net deferred tax assets in the U.S. will not be realized, and accordingly continued to record a valuation allowance. The evidence considered included the magnitude of the current three-year cumulative income compared to historical losses, expected impact of tax planning strategies, interest rates, and the overall business environment. The Company continues to evaluate its cumulative income position and income trend as well as its future projections of sustained profitability and whether this profitability trend constitutes sufficient positive evidence to support a reversal of the valuation allowance (in full or in part). The amount of the valuation allowance recorded in the U.S. as of December 31, 2013 was $837 million.

Debt

Debt	3 Months Ended
	Mar. 31, 2014
Debt	'
Debt	'
	8.  Debt
	The following table summarizes the long-term debt of the Company:
		March 31,			December 31,			March 31,
		2014			2013			2013
	Secured Credit Agreement:
	Revolving Credit Facility:
	Revolving Loans	$	150		$	—		$	126
	Term Loans:
	Term Loan A							53
	Term Loan B	405			405			525
	Term Loan C (81 million CAD at March 31, 2014)	74			76			100
	Term Loan D (€85 million at March 31, 2014)	116			117			158
	Senior Notes:
	3.00%, Exchangeable, due 2015	621			617			647
	7.375%, due 2016	594			593			591
	6.75%, due 2020 (€500 million)	688			690			641
	4.875%, due 2021 (€330 million)	454			455			423
	Senior Debentures:
	7.80%, due 2018	250			250			250
	Other	60			58			92
	Total long-term debt	3,412			3,261			3,606
	Less amounts due within one year	41			16			56
	Long-term debt	$	3,371		$	3,245		$	3,550
	On May 19, 2011, the Company’s subsidiary borrowers entered into the Secured Credit Agreement (the “Agreement”).  At March 31, 2014, the Agreement included a $900 million revolving credit facility, a $405 million term loan, a 81 million Canadian dollar term loan, and a €85 million term loan, each of which has a final maturity date of May 19, 2016.  At March 31, 2014, the Company’s subsidiary borrowers had unused credit of $660 million available under the Agreement.
	The weighted average interest rate on borrowings outstanding under the Agreement at March 31, 2014 was 2.02%.
	During March 2013, the Company issued senior notes with a face value of €330 million due March 31, 2021. The notes bear interest at 4.875% and are guaranteed by substantially all of the Company’s domestic subsidiaries. The net proceeds, after deducting debt issuance costs, totaled approximately $418 million.
	During March 2013, the Company discharged, in accordance with the indenture, all €300 million of the 6.875% senior notes due 2017. The Company recorded $11 million of additional interest charges for note repurchase premiums and the related write-off of unamortized finance fees.
	The Company has a €215 million European accounts receivable securitization program, which extends through September 2016, subject to periodic renewal of backup credit lines.  Information related to the Company’s accounts receivable securitization program is as follows:
		March 31,			December 31,			March 31,
		2014			2013			2013
	Balance (included in short-term loans)	$	253		$	276		$	241
	Weighted average interest rate	1.53		%	1.41		%	1.38		%
	The carrying amounts reported for the accounts receivable securitization program, and certain long-term debt obligations subject to frequently redetermined interest rates, approximate fair value.  Fair values for the Company’s significant fixed rate debt obligations are based on published market quotations, and are classified as Level 1 in the fair value hierarchy.
	Fair values at March 31, 2014 of the Company’s significant fixed rate debt obligations are as follows:
					Indicated
		Principal			Market		Fair
		Amount			Price		Value
	Senior Notes:
	3.00%, Exchangeable, due 2015	$	644		103.51		$	667
	7.375%, due 2016	600			111		666
	6.75%, due 2020 (€500 million)	688			118.33		814
	4.875%, due 2021 (€330 million)	454			107.39		488
	Senior Debentures:
	7.80%, due 2018	250			117		293

Contingencies

Contingencies	3 Months Ended
	Mar. 31, 2014
Contingencies	'
Contingencies	'
	9.  Contingencies
	Asbestos
	The Company is a defendant in numerous lawsuits alleging bodily injury and death as a result of exposure to asbestos dust.  From 1948 to 1958, one of the Company’s former business units commercially produced and sold approximately $40 million of a high-temperature, calcium-silicate based pipe and block insulation material containing asbestos.  The Company exited the pipe and block insulation business in April 1958.  The typical asbestos personal injury lawsuit alleges various theories of liability, including negligence, gross negligence and strict liability and seeks compensatory and in some cases, punitive damages in various amounts (herein referred to as “asbestos claims”).
	As of March 31, 2014, the Company has determined that it is a named defendant in asbestos lawsuits and claims involving approximately 2,500 plaintiffs and claimants.  Based on an analysis of the lawsuits pending as of December 31, 2013, approximately 80% of plaintiffs either do not specify the monetary damages sought, or in the case of court filings, claim an amount sufficient to invoke the jurisdictional minimum of the trial court.  Approximately 16% of plaintiffs specifically plead damages above the jurisdictional minimum up to, and including, $15 million or less, and 3% of plaintiffs specifically plead damages greater than $15 million but less than $100 million.  Fewer than 1% of plaintiffs specifically plead damages equal to or greater than $100 million.
	As indicated by the foregoing summary, current pleading practice permits considerable variation in the assertion of monetary damages.  The Company’s experience resolving hundreds of thousands of asbestos claims and lawsuits over an extended period demonstrates that the monetary relief that may be alleged in a complaint bears little relevance to a claim’s merits or disposition value.  Rather, the amount potentially recoverable is determined by such factors as the severity of the plaintiff’s asbestos disease, the product identification evidence against the Company and other defendants, the defenses available to the Company and other defendants, the specific jurisdiction in which the claim is made, and the plaintiff’s medical history and exposure to other disease-causing agents.
	In addition to the pending claims set forth above, the Company has claims-handling agreements in place with many plaintiffs’ counsel throughout the country.  These agreements require evaluation and negotiation regarding whether particular claimants qualify under the criteria established by such agreements. The criteria for such claims include verification of a compensable illness and a reasonable probability of exposure to a product manufactured by the Company’s former business unit during its manufacturing period ending in 1958.
	The Company has also been a defendant in other asbestos-related lawsuits or claims involving maritime workers, medical monitoring claimants, co-defendants and property damage claimants.  Based upon its past experience, the Company believes that these categories of lawsuits and claims will not involve any material liability and they are not included in the above description of pending matters or in the following description of disposed matters.
	Since receiving its first asbestos claim, the Company as of March 31, 2014, has disposed of the asbestos claims of approximately 393,000 plaintiffs and claimants at an average indemnity payment per claim of approximately $8,700.  Certain of these dispositions have included deferred amounts payable over a number of years.  Deferred amounts payable totaled approximately $24 million at March 31, 2014 ($12 million at December 31, 2013) and are included in the foregoing average indemnity payment per claim.  The Company’s asbestos indemnity payments have varied on a per claim basis, and are expected to continue to vary considerably over time.  As discussed above, a part of the Company’s objective is to achieve, where possible, resolution of asbestos claims pursuant to claims-handling agreements.  Failure of claimants to meet certain medical and product exposure criteria in the Company’s administrative claims handling agreements has generally reduced the number of marginal or suspect claims that would otherwise have been received.  In addition, certain courts and legislatures have reduced or eliminated the number of marginal or suspect claims that the Company otherwise would have received.  These developments generally have had the effect of increasing the Company’s per-claim average indemnity payment over time.
	The Company believes that its ultimate asbestos-related liability (i.e., its indemnity payments or other claim disposition costs plus related legal fees) cannot reasonably be estimated. Beginning with the initial liability of $975 million established in 1993, the Company has accrued a total of approximately $4.3 billion through 2013, before insurance recoveries, for its asbestos-related liability.  The Company’s ability to reasonably estimate its liability has been significantly affected by, among other factors, the volatility of asbestos-related litigation in the United States, the significant number of co-defendants that have filed for bankruptcy, the magnitude and timing of co-defendant bankruptcy trust payments, the inherent uncertainty of future disease incidence and claiming patterns against the Company, and the success of efforts by co-defendants to restrict or eliminate their liability in the litigation.
	The Company has continued to monitor trends that may affect its ultimate liability and has continued to analyze the developments and variables affecting or likely to affect the resolution of pending and future asbestos claims against the Company.  The material components of the Company’s accrued liability are based on amounts determined by the Company in connection with its annual comprehensive review and consist of the following estimates, to the extent it is probable that such liabilities have been incurred and can be reasonably estimated: (i) the liability for asbestos claims already asserted against the Company; (ii) the liability for asbestos claims not yet asserted against the Company, but which the Company believes will be asserted in the next several years; and (iii) the legal defense costs likely to be incurred in connection with the foregoing types of claims.
	The significant assumptions underlying the material components of the Company’s accrual are:
	a)             the extent to which settlements are limited to claimants who were exposed to the Company’s asbestos-containing insulation prior to its exit from that business in 1958;
	b)             the extent to which claims are resolved under the Company’s administrative claims agreements or on terms comparable to those set forth in those agreements;
	c)              the extent of decrease or increase in the incidence of serious disease cases and claiming patterns for such cases;
	d)             the extent to which the Company is able to defend itself successfully at trial or on appeal;
	e)              the number and timing of additional co-defendant bankruptcies; and
	f)               the extent to which co-defendants with substantial resources and assets continue to participate significantly in the resolution of future asbestos lawsuits and claims.
	As noted above, the Company conducts a comprehensive review of its asbestos-related liabilities and costs annually in connection with finalizing and reporting its annual results of operations, unless significant changes in trends or new developments warrant an earlier review.  If the results of an annual comprehensive review indicate that the existing amount of the accrued liability is insufficient to cover its estimated future asbestos-related costs, then the Company will record an appropriate charge to increase the accrued liability.  The Company believes that a reasonable estimation of the probable amount of the liability for claims not yet asserted against the Company is not possible beyond a period of several years.  Therefore, while the results of future annual comprehensive reviews cannot be determined, the Company expects the addition of one year to the estimation period will result in an annual charge.
	The Company’s reported results of operations for 2013 were materially affected by the $145 million fourth quarter charge for asbestos-related costs and asbestos-related payments continue to be substantial.  Any future additional charge would likewise materially affect the Company’s results of operations for the period in which it is recorded. Also, the continued use of significant amounts of cash for asbestos-related costs has affected and may continue to affect the Company’s cost of borrowing and its ability to pursue global or domestic acquisitions. However, the Company believes that its operating cash flows and other sources of liquidity will be sufficient to pay its obligations for asbestos-related costs and to fund its working capital and capital expenditure requirements on a short-term and long-term basis.
	Other Matters
	The Company conducted an internal investigation into conduct in certain of its overseas operations that may have violated the anti-bribery provisions of the United States Foreign Corrupt Practices Act (the “FCPA”), the FCPA’s books and records and internal controls provisions, the Company’s own internal policies, and various local laws.  In October 2012, the Company voluntarily disclosed these matters to the U.S. Department of Justice (the “DOJ”) and the Securities and Exchange Commission (the “SEC”).
	On July 18, 2013, the Company received a letter from the DOJ indicating that it presently did not intend to take any enforcement action and is closing its inquiry into the matter.
	The Company is presently unable to predict the duration, scope or result of an investigation by the SEC, if any, or whether the SEC will commence any legal action.  The SEC has a broad range of civil sanctions under the FCPA and other laws and regulations including, but not limited to, injunctive relief, disgorgement, penalties, and modifications to business practices.  The Company could also be subject to investigation and sanctions outside the United States.  While the Company is currently unable to quantify the impact of any potential sanctions or remedial measures, it does not expect such actions will have a material adverse effect on the Company’s liquidity, results of operations or financial condition.
	The Company received a non-income tax assessment from a foreign tax authority for approximately $90 million (including penalties and interest). The Company challenged this assessment, but the tax authority’s position was upheld in court. The Company strongly disagrees with this ruling and believes it to be contradictory to other court rulings in the Company’s favor. Although the Company cannot predict the ultimate outcome of this case, it believes that it is probable that the tax authority’s assessment will be overturned by a higher court, and therefore, the Company has not established an accrual. In order to contest the lower court rulings, legal rules require the Company to deposit the amount of the tax assessment, which will be remitted in monthly installments over the next fifteen months. A favorable ruling by the higher court will result in a return to the Company of amounts paid. An unfavorable ruling will result in the forfeiture of the deposit, a charge of approximately $60 million and a non-income tax refund of $30 million.  As of March 31, 2014, the Company has made installment payments totaling $60 million, which is included in Other assets on the balance sheet.
	Other litigation is pending against the Company, in many cases involving ordinary and routine claims incidental to the business of the Company and in others presenting allegations that are non-routine and involve compensatory, punitive or treble damage claims as well as other types of relief.  The Company records a liability for such matters when it is both probable that the liability has been incurred and the amount of the liability can be reasonably estimated.  Recorded amounts are reviewed and adjusted to reflect changes in the factors upon which the estimates are based, including additional information, negotiations, settlements and other events.

Share_Owners_Equity

Share Owners' Equity	3 Months Ended
	Mar. 31, 2014
Share Owners' Equity	'
Share Owners' Equity	'
	10.  Share Owners’ Equity
	The activity in share owners’ equity for the three months ended March 31, 2014 and 2013 is as follows:
		Share Owners’ Equity of the Company
		Common			Capital in		Treasury			Retained			Accumulated			Non-			Total Share
		Stock			Excess of		Stock			Earnings			Other			controlling			Owners’
					Par Value					(Loss)			Comprehensive			Interests			Equity
													Loss
	Balance on January 1, 2014	$	2		$	3,040	$	(454	)	$	(11	)	$	(1,121	)	$	147		$	1,603
	Issuance of common stock (155,727 shares)				4														4
	Reissuance of common stock (48,041 shares)						2												2
	Stock compensation				8														8
	Net earnings									101						5			106
	Other comprehensive income (loss)												59			(3		)	56
	Distributions to noncontrolling interests															(19		)	(19		)
	Balance on March 31, 2014	$	2		$	3,052	$	(452	)	$	90		$	(1,062	)	$	130		$	1,760
		Share Owners’ Equity of the Company
		Common			Capital in		Treasury			Retained			Accumulated			Non-			Total Share
		Stock			Excess of		Stock			Loss			Other			controlling			Owners’
					Par Value								Comprehensive			Interests			Equity
													Loss
	Balance on January 1, 2013	$	2		$	3,005	$	(425	)	$	(195	)	$	(1,506	)	$	174		$	1,055
	Issuance of common stock (315,704 shares)				4														4
	Reissuance of common stock (40,771 shares)						1												1
	Stock compensation				4														4
	Net earnings									69						5			74
	Other comprehensive income (loss)												21			(4		)	17
	Balance on March 31, 2013	$	2		$	3,013	$	(424	)	$	(126	)	$	(1,485	)	$	175		$	1,155
	The Company has 250,000,000 shares of common stock authorized with a par value of $.01 per share. Shares outstanding are as follows:
		Shares Outstanding
		March 31,		December 31,		March 31,
	(share amounts in thousands)	2014		2013		2013
	Shares of common stock issued (including treasury shares)	183,811		183,500		182,356
	Treasury shares, at cost	18,738		18,786		17,861

Accumulated_Other_Comprehensiv

Accumulated Other Comprehensive Loss	3 Months Ended
	Mar. 31, 2014
Accumulated Other Comprehensive Loss	'
Accumulated Other Comprehensive Loss	'
	11. Accumulated Other Comprehensive Loss
	The activity in accumulated other comprehensive loss for the three months ended March 31, 2014 and 2013 is as follows:
		Net Effect of			Change in			Employee Benefit			Total
		Exchange Rate			Certain Derivative			Plans			Accumulated
		Fluctuations			Instruments						Other
											Comprehensive
											Loss
	Balance on January 1, 2014	$	229		$	(12	)	$	(1,338	)	$	(1,121	)
	Change before reclassifications	35			2						37
	Amounts reclassified from accumulated other comprehensive income				(1		)(a)	23		(b)	22
	Translation effect							1			1
	Tax effect							(1		)	(1		)
	Other comprehensive income attributable to the Company	35			1			23			59
	Balance on March 31, 2014	$	264		$	(11	)	$	(1,315	)	$	(1,062	)
		Net Effect of			Change in			Employee Benefit			Total
		Exchange Rate			Certain Derivative			Plans			Accumulated
		Fluctuations			Instruments						Other
											Comprehensive
											Loss
	Balance on January 1, 2013	$	455		$	(14	)	$	(1,947	)	$	(1,506	)
	Change before reclassifications	(28		)	3						(25		)
	Amounts reclassified from accumulated other comprehensive income				1		(a)	37		(b)	38
	Translation effect							10			10
	Tax effect							(2		)	(2		)
	Other comprehensive income attributable to the Company	(28		)	4			45			21
	Balance on March 31, 2013	$	427		$	(10	)	$	(1,902	)	$	(1,485	)
	(a)         Amount is included in Cost of goods sold on the Condensed Consolidated Results of Operations (see Note 4 for additional information).
	(b)         Amount is included in the computation of net periodic pension cost (see Note 6 for additional information) and net postretirement benefit cost.

Other_Expense

Other Expense	3 Months Ended
	Mar. 31, 2014
Other Expense	'
Other Expense	'
	12. Other Expense
	During the three months ended March 31, 2013, the Company recorded charges of $10 million for restructuring, asset impairment and related charges primarily related to the Company’s European Asset Optimization program.  See Note 5 for additional information.

Earnings_Per_Share

Earnings Per Share	3 Months Ended
	Mar. 31, 2014
Earnings Per Share	'
Earnings Per Share	'
	13. Earnings Per Share
	The following table sets forth the computation of basic and diluted earnings per share:
		Three months ended March 31,
		2014			2013
	Numerator:
	Net earnings attributable to the Company	$	101		$	69
	Denominator (in thousands):
	Denominator for basic earnings per share - weighted average shares outstanding	164,760			164,069
	Effect of dilutive securities:
	Stock options and other	1,405			1,432
	Denominator for diluted earnings per share - adjusted weighted average shares outstanding	166,165			165,501
	Basic earnings per share:
	Earnings from continuing operations	$	0.62		$	0.48
	Loss from discontinued operations	(0.01		)	(0.06		)
	Net earnings	$	0.61		$	0.42
	Diluted earnings per share:
	Earnings from continuing operations	$	0.62		$	0.48
	Loss from discontinued operations	(0.01		)	(0.06		)
	Net earnings	$	0.61		$	0.42
	Options to purchase 370,012 and 1,640,504 weighted average shares of common stock which were outstanding during the three months ended March 31, 2014 and 2013, respectively, were not included in the computation of diluted earnings per share because the options’ exercise price was greater than the average market price of the common shares.
	The 2015 Exchangeable Notes have a dilutive effect only in those periods in which the Company’s average stock price exceeds the exchange price of $47.47 per share.  For the three months ended March 31, 2014 and 2013, the Company’s average stock price did not exceed the exchange price.  Therefore, the potentially issuable shares resulting from the settlement of the 2015 Exchangeable Notes were not included in the calculation of diluted earnings per share.

Supplemental_Cash_Flow_Informa

Supplemental Cash Flow Information	3 Months Ended
	Mar. 31, 2014
Supplemental Cash Flow Information	'
Supplemental Cash Flow Information	'
	14.  Supplemental Cash Flow Information
		Three months ended March 31,
		2014		2013
	Interest paid in cash	$	70	$	81
	Income taxes paid in cash (non-U.S.)	$	31	$	33
	Cash interest for 2013 includes note repurchase premiums of $9 million related to the discharge of the Company’s 6.875% senior notes due 2017.

Discontinued_Operations

Discontinued Operations	3 Months Ended
	Mar. 31, 2014
Discontinued Operations	'
Discontinued Operations	'
	15.  Discontinued Operations
	The loss from discontinued operations of $1 million for the three months ended March 31, 2014 is related to ongoing costs for the 2010 Venezuela expropriation. The loss from discontinued operations of $10 million for the three months ended March 31, 2013 included $8 million of special termination benefits related to a previously disposed business and $2 million for ongoing costs related to the Venezuela expropriation.

Financial_Information_for_Subs

Financial Information for Subsidiary Guarantors and Non-Guarantors	3 Months Ended
	Mar. 31, 2014
Financial Information for Subsidiary Guarantors and Non-Guarantors	'
Financial Information for Subsidiary Guarantors and Non-Guarantors	'
	16.  Financial Information for Subsidiary Guarantors and Non-Guarantors
	The following presents condensed consolidating financial information for the Company, segregating:  (1) Owens-Illinois, Inc., the issuer of senior debentures (the “Parent”); (2) the two subsidiaries which have guaranteed the senior debentures on a subordinated basis (the “Guarantor Subsidiaries”); and (3) all other subsidiaries (the “Non-Guarantor Subsidiaries”).  The Guarantor Subsidiaries are 100% owned direct and indirect subsidiaries of the Company and their guarantees are full, unconditional and joint and several.  They have no operations and function only as intermediate holding companies.
	Certain reclassifications have been made to conform all of the financial information to the financial presentation on a consolidated basis.  The principal eliminations relate to investments in subsidiaries and intercompany balances and transactions.
		March 31, 2014
							Non-
					Guarantor		Guarantor
		Parent			Subsidiaries		Subsidiaries			Eliminations			Consolidated
	Balance Sheet
	Current assets:
	Cash and cash equivalents	$	—		$	—	$	201		$	—		$	201
	Receivables						1,078						1,078
	Inventories						1,204						1,204
	Prepaid expenses						94						94
	Total current assets	—			—		2,577			—			2,577
	Investments in and advances to subsidiaries	2,313			2,063					(4,376		)	—
	Property, plant and equipment, net						2,634						2,634
	Goodwill						2,059						2,059
	Other assets						1,218						1,218
	Total assets	$	2,313		$	2,063	$	8,488		$	(4,376	)	$	8,488
	Current liabilities:
	Short-term loans and long-term debt due within one year	$	—		$	—	$	331		$	—		$	331
	Current portion of asbestos liability	150											150
	Accounts payable						1,074						1,074
	Other liabilities						527						527
	Total current liabilities	150			—		1,932			—			2,082
	Long-term debt	250					3,371			(250		)	3,371
	Asbestos-related liabilities	283											283
	Other long-term liabilities						992						992
	Share owners’ equity	1,630			2,063		2,193			(4,126		)	1,760
	Total liabilities and share owners’ equity	$	2,313		$	2,063	$	8,488		$	(4,376	)	$	8,488
		December 31, 2013
							Non-
					Guarantor		Guarantor
	Balance Sheet	Parent			Subsidiaries		Subsidiaries			Eliminations			Consolidated
	Current assets:
	Cash and cash equivalents	$	—		$	—	$	383		$	—		$	383
	Receivables						943						943
	Inventories						1,117						1,117
	Prepaid expenses						107						107
	Total current assets						2,550						2,550
	Investments in and advances to subsidiaries	2,154			1,904					(4,058		)	—
	Property, plant and equipment, net						2,632						2,632
	Goodwill						2,059						2,059
	Other assets						1,178						1,178
	Total assets	$	2,154		$	1,904	$	8,419		$	(4,058	)	$	8,419
	Current liabilities:
	Short-term loans and long-term debt due within one year	$	—		$	—	$	322		$	—		$	322
	Current portion of asbestos liability	150											150
	Accounts payable						1,144						1,144
	Other liabilities						638						638
	Total current liabilities	150			—		2,104			—			2,254
	Long-term debt	250					3,245			(250		)	3,245
	Asbestos-related liabilities	298											298
	Other long-term liabilities						1,019						1,019
	Share owners’ equity	1,456			1,904		2,051			(3,808		)	1,603
	Total liabilities and share owners’ equity	$	2,154		$	1,904	$	8,419		$	(4,058	)	$	8,419
		March 31, 2013
							Non-
					Guarantor		Guarantor
	Balance Sheet	Parent			Subsidiaries		Subsidiaries			Eliminations			Consolidated
	Current assets:
	Cash and cash equivalents	$	—		$	—	$	359		$	—		$	359
	Receivables						1,047						1,047
Inventories						1,178						1,178
Prepaid expenses						99						99
Total current assets	—			—		2,683			—			2,683
Investments in and advances to subsidiaries	1,674			1,424					(3,098		)	—
Property, plant and equipment, net						2,680						2,680
Goodwill						2,048						2,048
Other assets						1,106						1,106
Total assets	$	1,674		$	1,424	$	8,517		$	(3,098	)	$	8,517
Current liabilities:
Short-term loans and long-term debt due within one year	$	—		$	—	$	347		$	—		$	347
Current portion of asbestos liability	155											155
Accounts payable						904						904
Other liabilities						523						523
Total current liabilities	155			—		1,774			—			1,929
Long-term debt	250					3,550			(250		)	3,550
Asbestos-related liabilities	289											289
Other long-term liabilities						1,594						1,594
Share owners’ equity	980			1,424		1,599			(2,848		)	1,155
Total liabilities and share owners’ equity	$	1,674		$	1,424	$	8,517		$	(3,098	)	$	8,517
	Three months ended March 31, 2014
						Non-
				Guarantor		Guarantor
Results of Operations	Parent			Subsidiaries		Subsidiaries			Eliminations			Consolidated
Net sales	$	—		$	—	$	1,639		$	—		$	1,639
Cost of goods sold						(1,318		)				(1,318		)
Gross profit	—			—		321			—			321
Selling and administrative expense						(133		)				(133		)
Research, development and engineering expense						(15		)				(15		)
Net intercompany interest	5					(5		)				—
Interest expense, net	(5		)			(49		)				(54		)
Equity earnings from subsidiaries	101			101					(202		)	—
Other equity earnings						16						16
Other expense, net						(1		)				(1		)
Earnings before income taxes	101			101		134			(202		)	134
Provision for income taxes						(27		)				(27		)
Earnings from continuing operations	101			101		107			(202		)	107
Loss from discontinued operations						(1		)				(1		)
Net earnings	101			101		106			(202		)	106
Net earnings attributable to noncontrolling interests						(5		)				(5		)
Net earnings attributable to the Company	$	101		$	101	$	101		$	(202	)	$	101
	Three months ended March 31, 2014
						Non-
				Guarantor		Guarantor
Comprehensive Income	Parent			Subsidiaries		Subsidiaries			Eliminations			Consolidated
Net earnings	$	101		$	101	$	106		$	(202	)	$	106
Other comprehensive income, net	59			59		37			(99		)	56
Total comprehensive income	160			160		143			(301		)	162
Comprehensive income attributable to noncontrolling interests						(2		)				(2		)
Comprehensive income attributable to the Company	$	160		$	160	$	141		$	(301	)	$	160
	Three months ended March 31, 2013
						Non-
				Guarantor		Guarantor
Results of Operations	Parent			Subsidiaries		Subsidiaries			Eliminations			Consolidated
Net sales	$	—		$	—	$	1,641		$	—		$	1,641
Cost of goods sold						(1,322		)				(1,322		)
Gross profit	—			—		319			—			319
Selling and administrative expense						(129		)				(129		)
Research, development and engineering expense						(15		)				(15		)
Net intercompany interest	5					(5		)				—
Interest expense, net	(5		)			(63		)				(68		)
Equity earnings from subsidiaries	69			69					(138		)	—
Other equity earnings						17						17
Other expense, net						(7		)				(7		)
Earnings before income taxes	69			69		117			(138		)	117
Provision for income taxes						(33		)				(33		)
Earnings from continuing operations	69			69		84			(138		)	84
Loss from discontinued operations						(10		)				(10		)
Net earnings	69			69		74			(138		)	74
Net earnings attributable to noncontrolling interests						(5		)				(5		)
Net earnings attributable to the Company	$	69		$	69	$	69		$	(138	)	$	69
	Three months ended March 31, 2013
						Non-
				Guarantor		Guarantor
Comprehensive Income	Parent			Subsidiaries		Subsidiaries			Eliminations			Consolidated
Net earnings	$	69		$	69	$	74		$	(138	)	$	74
Other comprehensive income, net	21			21		(12		)	(13		)	17
Total comprehensive income	90			90		62			(151		)	91
Comprehensive income attributable to noncontrolling interests						(1		)				(1		)
Comprehensive income attributable to the Company	$	90		$	90	$	61		$	(151	)	$	90
	Three months ended March 31, 2014
						Non-
				Guarantor		Guarantor
Cash Flows	Parent			Subsidiaries		Subsidiaries			Eliminations			Consolidated
Cash utilized in operating activities	$	(15	)	$	—	$	(188	)	$	—		$	(203	)
Cash utilized in investing activities						(95		)				(95		)
Cash provided by financing activities	15					107						122
Effect of exchange rate change on cash						(6		)				(6		)
Net change in cash	—			—		(182		)	—			(182		)
Cash at beginning of period						383						383
Cash at end of period	$	—		$	—	$	201		$	—		$	201
	Three months ended March 31, 2013
						Non-
				Guarantor		Guarantor
Cash Flows	Parent			Subsidiaries		Subsidiaries			Eliminations			Consolidated
Cash utilized in operating activities	$	(17	)	$	—	$	(119	)	$	—		$	(136	)
Cash utilized in investing activities						(94		)				(94		)
Cash provided by financing activities	17					142						159
Effect of exchange rate change on cash						(1		)				(1		)
Net change in cash	—			—		(72		)	—			(72		)
Cash at beginning of period						431						431
Cash at end of period	$	—		$	—	$	359		$	—		$	359

Segment_Information_Tables

Segment Information (Tables)	3 Months Ended
	Mar. 31, 2014
Segment Information	'
Net sales for the Company's reportable segments	'
		2014			2013
	Net sales:
	Europe	$	706		$	650
	North America	485			469
	South America	239			269
	Asia Pacific	203			247
	Reportable segment totals	1,633			1,635
	Other	6			6
	Net sales	$	1,639		$	1,641
Segment operating profit for the Company's reportable segments	'
		2014			2013
	Segment operating profit:
	Europe	$	87		$	59
	North America	65			74
	South America	41			53
	Asia Pacific	25			40
	Reportable segment totals	218			226
	Items excluded from segment operating profit:
	Retained corporate costs and other	(30		)	(31		)
	Restructuring, asset impairment and related charges				(10		)
	Interest expense, net	(54		)	(68		)
	Earnings from continuing operations before income taxes	$	134		$	117
Total assets for the Company's reportable segments	'
		March 31,			December 31,			March 31,
		2014			2013			2013
	Total assets:
	Europe	$	3,585		$	3,509		$	3,263
	North America	2,055			1,995			2,030
	South America	1,453			1,467			1,638
	Asia Pacific	1,142			1,150			1,294
	Reportable segment totals	8,235			8,121			8,225
	Other	253			298			292
	Consolidated totals	$	8,488		$	8,419		$	8,517

Receivables_Tables

Receivables (Tables)	3 Months Ended
	Mar. 31, 2014
Receivables	'
Schedule of receivables	'
		March 31,		December 31,		March 31,
		2014		2013		2013
	Trade accounts receivable	$	911	$	757	$	903
	Less: allowances for doubtful accounts and discounts	39		39		41
	Net trade receivables	872		718		862
	Other receivables	206		225		185
		$	1,078	$	943	$	1,047

Inventories_Tables

Inventories (Tables)	3 Months Ended
	Mar. 31, 2014
Inventories	'
Major classes of inventory	'
		March 31,		December 31,		March 31,
		2014		2013		2013
	Finished goods	$	1,037	$	958	$	1,014
	Raw materials	121		113		124
	Operating supplies	46		46		40
		$	1,204	$	1,117	$	1,178

Derivative_Instruments_Tables

Derivative Instruments (Tables)	3 Months Ended
	Mar. 31, 2014
Derivative Instruments	'
Effect of commodity futures contracts designated as cash flow hedges on the results of operations	'
							Amount of Gain (Loss)
	Amount of Gain						Reclassified from
	Recognized in OCI on						Accumulated OCI into Income
	Commodity Futures Contracts						(reported in Cost of goods sold)
	(Effective Portion)						(Effective Portion)
	2014			2013			2014			2013
	$	2		$	3		$	1		$	(1	)
Effect of the forward exchange contracts not designated as hedging instruments on the results of operations	'
			Amount of Loss
	Location of Gain (Loss)		Recognized in Income on
	Recognized in Income on		Forward Exchange Contracts
	Forward Exchange Contracts		2014			2013
	Other expense, net		$	(1	)	$	(3	)
Balance Sheet Classification of derivative instruments	'
			Balance		Fair Value
			Sheet		March 31,			December 31,			March 31,
			Location		2014			2013			2013
	Asset Derivatives:
	Derivatives designated as hedging instruments:
	Commodity futures contracts		a		$	2		$	1		$	2
	Derivatives not designated as hedging instruments:
	Foreign exchange contracts		a		4			3			3
	Foreign exchange contracts		c		3						1
	Total derivatives not designated as hedging instruments				7			3			4
	Total asset derivatives				$	9		$	4		$	6
	Liability Derivatives:
	Derivatives not designated as hedging instruments:
	Foreign exchange contracts		c		$	10		$	7		$	8
	Total liability derivatives				$	10		$	7		$	8

Restructuring_Accruals_Tables

Restructuring Accruals (Tables)	3 Months Ended
	Mar. 31, 2014
Restructuring Accruals	'
Selected information related to the restructuring accruals	'
		European			Asia Pacific			Other			Total
		Asset			Restructuring			Restructuring			Restructuring
		Optimization						Actions
	Balance at January 1, 2014	$	30		$	20		$	64		$	114
	Net cash paid, principally severance and related benefits	(2		)	(4		)	(15		)	(21		)
	Other, including foreign exchange translation	(1		)	(4		)	(3		)	(8		)
	Balance at March 31, 2014	$	27		$	12		$	46		$	85
	Balance at January 1, 2013	$	53		$	6		$	64		$	123
	First quarter 2013 charges	7			2			1			10
	Write-down of assets to net realizable value	(2		)							(2		)
	Net cash paid, principally severance and related benefits	(20		)	(4		)	(10		)	(34		)
	Other, including foreign exchange translation	(1		)				(1		)	(2		)
	Balance at March 31, 2013	$	37		$	4		$	54		$	95

Pensions_Benefit_Plans_Tables

Pensions Benefit Plans (Tables) (Pension Benefit Plans)	3 Months Ended
	Mar. 31, 2014
Pension Benefit Plans	'
Defined Benefit Plans and Other Postretirement Benefit Plans	'
Components of net periodic pension cost (income) and net periodic postretirement (benefit) cost	'
		U.S.						Non-U.S.
		2014			2013			2014			2013
	Service cost	$	6		$	7		$	7		$	8
	Interest cost	27			27			18			17
	Expected asset return	(43		)	(46		)	(22		)	(23		)
	Amortization:
	Actuarial loss	18			28			4			8
	Net periodic pension cost	$	8		$	16		$	7		$	10

Debt_Tables

Debt (Tables)	3 Months Ended
	Mar. 31, 2014
Debt	'
Long-term Debt	'
		March 31,			December 31,			March 31,
		2014			2013			2013
	Secured Credit Agreement:
	Revolving Credit Facility:
	Revolving Loans	$	150		$	—		$	126
	Term Loans:
	Term Loan A							53
	Term Loan B	405			405			525
	Term Loan C (81 million CAD at March 31, 2014)	74			76			100
	Term Loan D (€85 million at March 31, 2014)	116			117			158
	Senior Notes:
	3.00%, Exchangeable, due 2015	621			617			647
	7.375%, due 2016	594			593			591
	6.75%, due 2020 (€500 million)	688			690			641
	4.875%, due 2021 (€330 million)	454			455			423
	Senior Debentures:
	7.80%, due 2018	250			250			250
	Other	60			58			92
	Total long-term debt	3,412			3,261			3,606
	Less amounts due within one year	41			16			56
	Long-term debt	$	3,371		$	3,245		$	3,550
Information related to accounts receivable securitization program	'
		March 31,			December 31,			March 31,
		2014			2013			2013
	Balance (included in short-term loans)	$	253		$	276		$	241
	Weighted average interest rate	1.53		%	1.41		%	1.38		%
Fair values of the Company's significant fixed rate debt obligations	'
					Indicated
		Principal			Market		Fair
		Amount			Price		Value
	Senior Notes:
	3.00%, Exchangeable, due 2015	$	644		103.51		$	667
	7.375%, due 2016	600			111		666
	6.75%, due 2020 (€500 million)	688			118.33		814
	4.875%, due 2021 (€330 million)	454			107.39		488
	Senior Debentures:
	7.80%, due 2018	250			117		293

Share_Owners_Equity_Tables

Share Owners' Equity (Tables)	3 Months Ended
	Mar. 31, 2014
Share Owners' Equity	'
Activity in share owners' equity	'
		Share Owners’ Equity of the Company
		Common			Capital in		Treasury			Retained			Accumulated			Non-			Total Share
		Stock			Excess of		Stock			Earnings			Other			controlling			Owners’
					Par Value					(Loss)			Comprehensive			Interests			Equity
													Loss
	Balance on January 1, 2014	$	2		$	3,040	$	(454	)	$	(11	)	$	(1,121	)	$	147		$	1,603
	Issuance of common stock (155,727 shares)				4														4
	Reissuance of common stock (48,041 shares)						2												2
	Stock compensation				8														8
	Net earnings									101						5			106
	Other comprehensive income (loss)												59			(3		)	56
	Distributions to noncontrolling interests															(19		)	(19		)
	Balance on March 31, 2014	$	2		$	3,052	$	(452	)	$	90		$	(1,062	)	$	130		$	1,760
		Share Owners’ Equity of the Company
		Common			Capital in		Treasury			Retained			Accumulated			Non-			Total Share
		Stock			Excess of		Stock			Loss			Other			controlling			Owners’
					Par Value								Comprehensive			Interests			Equity
													Loss
	Balance on January 1, 2013	$	2		$	3,005	$	(425	)	$	(195	)	$	(1,506	)	$	174		$	1,055
	Issuance of common stock (315,704 shares)				4														4
	Reissuance of common stock (40,771 shares)						1												1
	Stock compensation				4														4
	Net earnings									69						5			74
	Other comprehensive income (loss)												21			(4		)	17
	Balance on March 31, 2013	$	2		$	3,013	$	(424	)	$	(126	)	$	(1,485	)	$	175		$	1,155
Schedule of shares outstanding	'
		Shares Outstanding
		March 31,		December 31,		March 31,
	(share amounts in thousands)	2014		2013		2013
	Shares of common stock issued (including treasury shares)	183,811		183,500		182,356
	Treasury shares, at cost	18,738		18,786		17,861

Accumulated_Other_Comprehensiv1

Accumulated Other Comprehensive Loss (Tables)	3 Months Ended
	Mar. 31, 2014
Accumulated Other Comprehensive Loss	'
Component of accumulated other comprehensive loss	'
		Net Effect of			Change in			Employee Benefit			Total
		Exchange Rate			Certain Derivative			Plans			Accumulated
		Fluctuations			Instruments						Other
											Comprehensive
											Loss
	Balance on January 1, 2014	$	229		$	(12	)	$	(1,338	)	$	(1,121	)
	Change before reclassifications	35			2						37
	Amounts reclassified from accumulated other comprehensive income				(1		)(a)	23		(b)	22
	Translation effect							1			1
	Tax effect							(1		)	(1		)
	Other comprehensive income attributable to the Company	35			1			23			59
	Balance on March 31, 2014	$	264		$	(11	)	$	(1,315	)	$	(1,062	)
		Net Effect of			Change in			Employee Benefit			Total
		Exchange Rate			Certain Derivative			Plans			Accumulated
		Fluctuations			Instruments						Other
											Comprehensive
											Loss
	Balance on January 1, 2013	$	455		$	(14	)	$	(1,947	)	$	(1,506	)
	Change before reclassifications	(28		)	3						(25		)
	Amounts reclassified from accumulated other comprehensive income				1		(a)	37		(b)	38
	Translation effect							10			10
	Tax effect							(2		)	(2		)
	Other comprehensive income attributable to the Company	(28		)	4			45			21
	Balance on March 31, 2013	$	427		$	(10	)	$	(1,902	)	$	(1,485	)
	(a)         Amount is included in Cost of goods sold on the Condensed Consolidated Results of Operations (see Note 4 for additional information).
	(b)         Amount is included in the computation of net periodic pension cost (see Note 6 for additional information) and net postretirement benefit cost.

Earnings_Per_Share_Tables

Earnings Per Share (Tables)	3 Months Ended
	Mar. 31, 2014
Earnings Per Share	'
Computation of basic and diluted earnings per share	'
		Three months ended March 31,
		2014			2013
	Numerator:
	Net earnings attributable to the Company	$	101		$	69
	Denominator (in thousands):
	Denominator for basic earnings per share - weighted average shares outstanding	164,760			164,069
	Effect of dilutive securities:
	Stock options and other	1,405			1,432
	Denominator for diluted earnings per share - adjusted weighted average shares outstanding	166,165			165,501
	Basic earnings per share:
	Earnings from continuing operations	$	0.62		$	0.48
	Loss from discontinued operations	(0.01		)	(0.06		)
	Net earnings	$	0.61		$	0.42
	Diluted earnings per share:
	Earnings from continuing operations	$	0.62		$	0.48
	Loss from discontinued operations	(0.01		)	(0.06		)
	Net earnings	$	0.61		$	0.42

Supplemental_Cash_Flow_Informa1

Supplemental Cash Flow Information (Tables)	3 Months Ended
	Mar. 31, 2014
Supplemental Cash Flow Information	'
Supplemental Cash Flow Information	'
		Three months ended March 31,
		2014		2013
	Interest paid in cash	$	70	$	81
	Income taxes paid in cash (non-U.S.)	$	31	$	33

Financial_Information_for_Subs1

Financial Information for Subsidiary Guarantors and Non-Guarantors (Tables)	3 Months Ended
	Mar. 31, 2014
Financial Information for Subsidiary Guarantors and Non-Guarantors	'
Balance Sheet	'
		March 31, 2014
							Non-
					Guarantor		Guarantor
		Parent			Subsidiaries		Subsidiaries			Eliminations			Consolidated
	Balance Sheet
	Current assets:
	Cash and cash equivalents	$	—		$	—	$	201		$	—		$	201
	Receivables						1,078						1,078
	Inventories						1,204						1,204
	Prepaid expenses						94						94
	Total current assets	—			—		2,577			—			2,577
	Investments in and advances to subsidiaries	2,313			2,063					(4,376		)	—
	Property, plant and equipment, net						2,634						2,634
	Goodwill						2,059						2,059
	Other assets						1,218						1,218
	Total assets	$	2,313		$	2,063	$	8,488		$	(4,376	)	$	8,488
	Current liabilities:
	Short-term loans and long-term debt due within one year	$	—		$	—	$	331		$	—		$	331
	Current portion of asbestos liability	150											150
	Accounts payable						1,074						1,074
	Other liabilities						527						527
	Total current liabilities	150			—		1,932			—			2,082
	Long-term debt	250					3,371			(250		)	3,371
	Asbestos-related liabilities	283											283
	Other long-term liabilities						992						992
	Share owners’ equity	1,630			2,063		2,193			(4,126		)	1,760
	Total liabilities and share owners’ equity	$	2,313		$	2,063	$	8,488		$	(4,376	)	$	8,488
		December 31, 2013
							Non-
					Guarantor		Guarantor
	Balance Sheet	Parent			Subsidiaries		Subsidiaries			Eliminations			Consolidated
	Current assets:
	Cash and cash equivalents	$	—		$	—	$	383		$	—		$	383
	Receivables						943						943
	Inventories						1,117						1,117
	Prepaid expenses						107						107
	Total current assets						2,550						2,550
	Investments in and advances to subsidiaries	2,154			1,904					(4,058		)	—
	Property, plant and equipment, net						2,632						2,632
	Goodwill						2,059						2,059
	Other assets						1,178						1,178
	Total assets	$	2,154		$	1,904	$	8,419		$	(4,058	)	$	8,419
	Current liabilities:
	Short-term loans and long-term debt due within one year	$	—		$	—	$	322		$	—		$	322
	Current portion of asbestos liability	150											150
	Accounts payable						1,144						1,144
	Other liabilities						638						638
	Total current liabilities	150			—		2,104			—			2,254
	Long-term debt	250					3,245			(250		)	3,245
	Asbestos-related liabilities	298											298
	Other long-term liabilities						1,019						1,019
	Share owners’ equity	1,456			1,904		2,051			(3,808		)	1,603
	Total liabilities and share owners’ equity	$	2,154		$	1,904	$	8,419		$	(4,058	)	$	8,419
		March 31, 2013
							Non-
					Guarantor		Guarantor
	Balance Sheet	Parent			Subsidiaries		Subsidiaries			Eliminations			Consolidated
	Current assets:
	Cash and cash equivalents	$	—		$	—	$	359		$	—		$	359
	Receivables						1,047						1,047
	Inventories						1,178						1,178
	Prepaid expenses						99						99
	Total current assets	—			—		2,683			—			2,683
Investments in and advances to subsidiaries	1,674			1,424					(3,098		)	—
Property, plant and equipment, net						2,680						2,680
Goodwill						2,048						2,048
Other assets						1,106						1,106
Total assets	$	1,674		$	1,424	$	8,517		$	(3,098	)	$	8,517
Current liabilities:
Short-term loans and long-term debt due within one year	$	—		$	—	$	347		$	—		$	347
Current portion of asbestos liability	155											155
Accounts payable						904						904
Other liabilities						523						523
Total current liabilities	155			—		1,774			—			1,929
Long-term debt	250					3,550			(250		)	3,550
Asbestos-related liabilities	289											289
Other long-term liabilities						1,594						1,594
Share owners’ equity	980			1,424		1,599			(2,848		)	1,155
Total liabilities and share owners’ equity	$	1,674		$	1,424	$	8,517		$	(3,098	)	$	8,517
Results of Operations	'
		Three months ended March 31, 2014
							Non-
					Guarantor		Guarantor
	Results of Operations	Parent			Subsidiaries		Subsidiaries			Eliminations			Consolidated
	Net sales	$	—		$	—	$	1,639		$	—		$	1,639
	Cost of goods sold						(1,318		)				(1,318		)
	Gross profit	—			—		321			—			321
	Selling and administrative expense						(133		)				(133		)
	Research, development and engineering expense						(15		)				(15		)
	Net intercompany interest	5					(5		)				—
	Interest expense, net	(5		)			(49		)				(54		)
	Equity earnings from subsidiaries	101			101					(202		)	—
	Other equity earnings						16						16
	Other expense, net						(1		)				(1		)
	Earnings before income taxes	101			101		134			(202		)	134
	Provision for income taxes						(27		)				(27		)
	Earnings from continuing operations	101			101		107			(202		)	107
	Loss from discontinued operations						(1		)				(1		)
	Net earnings	101			101		106			(202		)	106
	Net earnings attributable to noncontrolling interests						(5		)				(5		)
	Net earnings attributable to the Company	$	101		$	101	$	101		$	(202	)	$	101
		Three months ended March 31, 2014
							Non-
					Guarantor		Guarantor
	Comprehensive Income	Parent			Subsidiaries		Subsidiaries			Eliminations			Consolidated
	Net earnings	$	101		$	101	$	106		$	(202	)	$	106
	Other comprehensive income, net	59			59		37			(99		)	56
	Total comprehensive income	160			160		143			(301		)	162
	Comprehensive income attributable to noncontrolling interests						(2		)				(2		)
	Comprehensive income attributable to the Company	$	160		$	160	$	141		$	(301	)	$	160
		Three months ended March 31, 2013
							Non-
					Guarantor		Guarantor
	Results of Operations	Parent			Subsidiaries		Subsidiaries			Eliminations			Consolidated
	Net sales	$	—		$	—	$	1,641		$	—		$	1,641
	Cost of goods sold						(1,322		)				(1,322		)
	Gross profit	—			—		319			—			319
	Selling and administrative expense						(129		)				(129		)
	Research, development and engineering expense						(15		)				(15		)
	Net intercompany interest	5					(5		)				—
	Interest expense, net	(5		)			(63		)				(68		)
	Equity earnings from subsidiaries	69			69					(138		)	—
	Other equity earnings						17						17
	Other expense, net						(7		)				(7		)
	Earnings before income taxes	69			69		117			(138		)	117
	Provision for income taxes						(33		)				(33		)
	Earnings from continuing operations	69			69		84			(138		)	84
	Loss from discontinued operations						(10		)				(10		)
	Net earnings	69			69		74			(138		)	74
	Net earnings attributable to noncontrolling interests						(5		)				(5		)
	Net earnings attributable to the Company	$	69		$	69	$	69		$	(138	)	$	69
		Three months ended March 31, 2013
							Non-
					Guarantor		Guarantor
	Comprehensive Income	Parent			Subsidiaries		Subsidiaries			Eliminations			Consolidated
	Net earnings	$	69		$	69	$	74		$	(138	)	$	74
	Other comprehensive income, net	21			21		(12		)	(13		)	17
	Total comprehensive income	90			90		62			(151		)	91
	Comprehensive income attributable to noncontrolling interests						(1		)				(1		)
	Comprehensive income attributable to the Company	$	90		$	90	$	61		$	(151	)	$	90
Cash Flows	'
		Three months ended March 31, 2014
							Non-
					Guarantor		Guarantor
	Cash Flows	Parent			Subsidiaries		Subsidiaries			Eliminations			Consolidated
	Cash utilized in operating activities	$	(15	)	$	—	$	(188	)	$	—		$	(203	)
	Cash utilized in investing activities						(95		)				(95		)
	Cash provided by financing activities	15					107						122
	Effect of exchange rate change on cash						(6		)				(6		)
	Net change in cash	—			—		(182		)	—			(182		)
	Cash at beginning of period						383						383
	Cash at end of period	$	—		$	—	$	201		$	—		$	201
		Three months ended March 31, 2013
							Non-
					Guarantor		Guarantor
	Cash Flows	Parent			Subsidiaries		Subsidiaries			Eliminations			Consolidated
	Cash utilized in operating activities	$	(17	)	$	—	$	(119	)	$	—		$	(136	)
	Cash utilized in investing activities						(94		)				(94		)
	Cash provided by financing activities	17					142						159
	Effect of exchange rate change on cash						(1		)				(1		)
	Net change in cash	—			—		(72		)	—			(72		)
	Cash at beginning of period						431						431
	Cash at end of period	$	—		$	—	$	359		$	—		$	359

Segment_Information_Details

Segment Information (Details) (USD $)	3 Months Ended
In Millions, unless otherwise specified	Mar. 31, 2014	Mar. 31, 2013
Net sales:	'	'
Net sales	$1,639	$1,641
Items excluded from Segment Operating Profit:	'	'
Retained corporate costs and other	-30	-31
Restructuring, asset impairment and related charges	'	-10
Interest expense, net	-54	-68
Earnings from continuing operations before income taxes	134	117
Reportable Segment Totals	'	'
Net sales:	'	'
Net sales	1,633	1,635
Segment Operating Profit:	'	'
Segment Operating Profit	218	226
Europe	'	'
Net sales:	'	'
Net sales	706	650
Segment Operating Profit:	'	'
Segment Operating Profit	87	59
North America	'	'
Net sales:	'	'
Net sales	485	469
Segment Operating Profit:	'	'
Segment Operating Profit	65	74
South America	'	'
Net sales:	'	'
Net sales	239	269
Segment Operating Profit:	'	'
Segment Operating Profit	41	53
Asia Pacific	'	'
Net sales:	'	'
Net sales	203	247
Segment Operating Profit:	'	'
Segment Operating Profit	25	40
Other	'	'
Net sales:	'	'
Net sales	$6	$6

Segment_Information_Details_2

Segment Information (Details 2) (USD $)	Mar. 31, 2014	Dec. 31, 2013	Mar. 31, 2013
In Millions, unless otherwise specified
Assets	'	'	'
Total assets:	$8,488	$8,419	$8,517
Reportable Segment Totals	'	'	'
Assets	'	'	'
Total assets:	8,235	8,121	8,225
Europe	'	'	'
Assets	'	'	'
Total assets:	3,585	3,509	3,263
North America	'	'	'
Assets	'	'	'
Total assets:	2,055	1,995	2,030
South America	'	'	'
Assets	'	'	'
Total assets:	1,453	1,467	1,638
Asia Pacific	'	'	'
Assets	'	'	'
Total assets:	1,142	1,150	1,294
Other	'	'	'
Assets	'	'	'
Total assets:	$253	$298	$292

Receivables_Details

Receivables (Details) (USD $)	3 Months Ended		12 Months Ended
In Millions, unless otherwise specified	Mar. 31, 2014	Mar. 31, 2013	Dec. 31, 2013
Receivables	'	'	'
Trade accounts receivable	$911	$903	$757
Less: allowances for doubtful accounts and discounts	39	41	39
Net trade receivables	872	862	718
Other receivables	206	185	225
Total	1,078	1,047	943
Amount of receivables sold	$129	$116	$192

Inventories_Details

Inventories (Details) (USD $)	Mar. 31, 2014	Dec. 31, 2013	Mar. 31, 2013
In Millions, unless otherwise specified
Inventories	'	'	'
Finished goods	$1,037	$958	$1,014
Raw materials	121	113	124
Operating supplies	46	46	40
Inventories	$1,204	$1,117	$1,178

Derivative_Instruments_Details

Derivative Instruments (Details) (USD $)	3 Months Ended
In Millions, unless otherwise specified	Mar. 31, 2014	Mar. 31, 2013
	MMBTU	MMBTU
Commodity futures contracts | Cash Flow Hedges	'	'
Derivatives and Hedges	'	'
Coverage of commodity futures contracts (in MM BTUs)	4,400,000	6,200,000
Unrecognized gain included in Accumulated OCI	$2	$2
Amount of Gain recognized in OCI on Commodity Futures Contracts (Effective Portion)	2	3
Commodity futures contracts gain (loss) reclassified from accumulated OCI into income	1	-1
Commodity futures contracts | Cash Flow Hedges | Minimum	'	'
Derivatives and Hedges	'	'
Period during which unrecognized gain included in Accumulated OCI will be reclassified into earnings	'12 months	'
Commodity futures contracts | Cash Flow Hedges | Maximum	'	'
Derivatives and Hedges	'	'
Period during which unrecognized gain included in Accumulated OCI will be reclassified into earnings	'24 months	'
Forward exchange contracts | Derivatives not designated as hedging instruments	'	'
Derivatives and Hedges	'	'
Forward exchange contracts in various currencies	670	900
Forward exchange contracts loss recognized in income	($1)	($3)

Derivative_Instruments_Details1

Derivative Instruments (Details 2) (USD $)	Mar. 31, 2014	Dec. 31, 2013	Mar. 31, 2013
In Millions, unless otherwise specified
Derivatives, Fair Value	'	'	'
Total asset derivatives	$9	$4	$6
Total liability derivatives	10	7	8
Derivatives designated as hedging instruments | Commodity futures contracts | Receivables	'	'	'
Derivatives, Fair Value	'	'	'
Total asset derivatives	2	1	2
Derivatives not designated as hedging instruments	'	'	'
Derivatives, Fair Value	'	'	'
Total asset derivatives	7	3	4
Derivatives not designated as hedging instruments | Foreign exchange contracts | Receivables	'	'	'
Derivatives, Fair Value	'	'	'
Total asset derivatives	4	3	3
Derivatives not designated as hedging instruments | Foreign exchange contracts | Other liabilities (current)	'	'	'
Derivatives, Fair Value	'	'	'
Total asset derivatives	3	'	1
Total liability derivatives	$10	$7	$8

Restructuring_Accruals_Details

Restructuring Accruals (Details) (USD $)	3 Months Ended
In Millions, unless otherwise specified	Mar. 31, 2014	Mar. 31, 2013
Restructuring accrual	'	'
Restructuring reserve balance at beginning of period	$114	$123
Charges	'	10
Write-down of assets to net realizable value	'	-2
Net cash paid, principally severance and related benefits	-21	-34
Other, including foreign exchange translation	-8	-2
Restructuring reserve balance at end of period	85	95
European Asset Optimization	'	'
Restructuring accrual	'	'
Restructuring reserve balance at beginning of period	30	53
Charges	'	7
Write-down of assets to net realizable value	'	-2
Net cash paid, principally severance and related benefits	-2	-20
Other, including foreign exchange translation	-1	-1
Restructuring reserve balance at end of period	27	37
Asia Pacific Restructuring	'	'
Restructuring accrual	'	'
Restructuring reserve balance at beginning of period	20	6
Charges	'	2
Net cash paid, principally severance and related benefits	-4	-4
Other, including foreign exchange translation	-4	'
Restructuring reserve balance at end of period	12	4
Other Restructuring Actions	'	'
Restructuring accrual	'	'
Restructuring reserve balance at beginning of period	64	64
Charges	'	1
Net cash paid, principally severance and related benefits	-15	-10
Other, including foreign exchange translation	-3	-1
Restructuring reserve balance at end of period	$46	$54

Pensions_Benefit_Plans_Details

Pensions Benefit Plans (Details) (USD $)	3 Months Ended
In Millions, unless otherwise specified	Mar. 31, 2014	Mar. 31, 2013
Amortization:	'	'
Special termination benefits	'	$8
U.S Pension Plans	'	'
Components of the net pension expense and postretirement benefit cost	'	'
Service cost	6	7
Interest cost	27	27
Expected asset return	-43	-46
Amortization:	'	'
Actuarial loss	18	28
Net periodic pension and postretirement benefit cost	8	16
Non-U.S. Pension Plans	'	'
Components of the net pension expense and postretirement benefit cost	'	'
Service cost	7	8
Interest cost	18	17
Expected asset return	-22	-23
Amortization:	'	'
Actuarial loss	4	8
Net periodic pension and postretirement benefit cost	$7	$10

Income_Taxes_Details

Income Taxes (Details) (USD $)	3 Months Ended
In Millions, unless otherwise specified	Mar. 31, 2014	Dec. 31, 2013
A reconciliation of the provision (benefit) for income taxes	'	'
Statutory U.S. Federal tax rate (as a percent)	35.00%	'
U.S. operations	'	'
Income taxes	'	'
Period of cumulative income position of the operations	'3 years	'
Valuation allowance	'	$837

Debt_Details

Debt (Details)

Mar. 31, 2014

Dec. 31, 2013

Mar. 31, 2013

Mar. 31, 2014

Mar. 31, 2014

Mar. 31, 2013

Mar. 31, 2013

Mar. 31, 2014

Dec. 31, 2013

Mar. 31, 2013

Mar. 31, 2014

Mar. 31, 2014

Dec. 31, 2013

Mar. 31, 2013

Mar. 31, 2014

Mar. 31, 2014

Dec. 31, 2013

Mar. 31, 2013

Mar. 31, 2014

Dec. 31, 2013

Mar. 31, 2013

Mar. 31, 2014

Dec. 31, 2013

Mar. 31, 2013

Mar. 31, 2013

Mar. 31, 2014

Mar. 31, 2013

Mar. 31, 2014

Mar. 31, 2014

Dec. 31, 2013

Mar. 31, 2013

Mar. 31, 2013

Mar. 31, 2014

Mar. 31, 2014

Dec. 31, 2013

Mar. 31, 2013

Mar. 31, 2014

Dec. 31, 2013

Mar. 31, 2013

Mar. 31, 2014

Dec. 31, 2013

Mar. 31, 2013

Mar. 31, 2014

Dec. 31, 2013

Mar. 31, 2013

Mar. 31, 2014

In Millions, except Per Share data, unless otherwise specified

USD ($)

USD ($)

USD ($)

Secured Credit Agreement

Revolving Loans

Revolving Loans

Term Loan A

Term Loan B

Term Loan B

Term Loan B

Term Loan C (81 million CAD at March 31, 2014)

Term Loan C (81 million CAD at March 31, 2014)

Term Loan C (81 million CAD at March 31, 2014)

Term Loan C (81 million CAD at March 31, 2014)

Term Loan D (EUR85 million at March 31, 2014)

Term Loan D (EUR85 million at March 31, 2014)

Term Loan D (EUR85 million at March 31, 2014)

Term Loan D (EUR85 million at March 31, 2014)

Senior Notes 3.00%, Exchangeable, due 2015

Senior Notes 3.00%, Exchangeable, due 2015

Senior Notes 3.00%, Exchangeable, due 2015

Senior Notes 7.375%, due 2016

Senior Notes 7.375%, due 2016

Senior Notes 7.375%, due 2016

Senior Notes 6.875%, due 2017 (300 million EUR)

Senior Notes 6.875%, due 2017 (300 million EUR)

Senior Notes 6.875%, due 2017 (300 million EUR)

Senior Notes 6.75%, due 2020 (500 million EUR)

Senior Notes 6.75%, due 2020 (500 million EUR)

Senior Notes 6.75%, due 2020 (500 million EUR)

Senior Notes 6.75%, due 2020 (500 million EUR)

Senior Notes 4.875%, due 2021 (330 million EUR)

Senior Notes 4.875%, due 2021 (330 million EUR)

Senior Notes 4.875%, due 2021 (330 million EUR)

Senior Notes 4.875%, due 2021 (330 million EUR)

Senior Notes 4.875%, due 2021 (330 million EUR)

Senior Debentures 7.80%, due 2018

Senior Debentures 7.80%, due 2018

Senior Debentures 7.80%, due 2018

Other debt

Other debt

Other debt

Accounts Receivable Securitization Program

Accounts Receivable Securitization Program

Accounts Receivable Securitization Program

European Accounts Receivable Securitization Program

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

CAD

USD ($)

USD ($)

USD ($)

EUR (€)

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

EUR (€)

USD ($)

EUR (€)

USD ($)

USD ($)

USD ($)

USD ($)

EUR (€)

USD ($)

EUR (€)

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

EUR (€)

Debt Instrument

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Total long-term debt

$3,412

$3,261

$3,606

'

$150

$126

$53

$405

$405

$525

$74

81

$76

$100

$116

€ 85

$117

$158

$621

$617

$647

$594

$593

$591

'

'

'

$688

€ 500

$690

$641

$423

$454

€ 330

$455

'

$250

$250

$250

$60

$58

$92

'

'

'

'

Less amounts due within one year

41

16

56

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Long-term debt

3,371

3,245

3,550

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Interest rate, stated percentage

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

3.00%

'

'

7.38%

'

'

'

6.88%

6.88%

6.75%

6.75%

'

'

'

4.88%

4.88%

'

'

7.80%

'

'

'

'

'

'

'

'

'

Maximum Borrowing Capacity

'

'

'

'

900

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

215

Unused Credit

'

'

'

660

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Weighted Average Interest Rate (as a percent)

'

'

'

2.02%

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Face Value

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

330

'

'

'

'

'

'

'

'

'

'

Net proceeds, after deducting debt issuance costs

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

418

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Debt discharge

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

300

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Interest charges for note repurchase premiums and related write-off of unamortized finance fees

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

11

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Short-term loans and long-term debt due within one year

331

322

347

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

253

276

241

'

Weighted Average Interest Rate, Short-term Debt (as a percent)

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

1.53%

1.41%

1.38%

'

Principal Amount

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

644

'

'

600

'

'

'

'

'

688

'

'

'

'

454

'

'

'

250

'

'

'

'

'

'

'

'

'

Indicated Market Price (in dollars per share)

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

$103.51

'

'

$111

'

'

'

'

'

$118.33

'

'

'

'

$107.39

'

'

'

$117

'

'

'

'

'

'

'

'

'

Fair Value

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

$667

'

'

$666

'

'

'

'

'

$814

'

'

'

'

$488

'

'

'

$293

'

'

'

'

'

'

'

'

'

Contingencies_Details

Contingencies (Details) (USD $)	3 Months Ended
	Mar. 31, 2014	Dec. 31, 2013	Dec. 31, 1993
	item
Percentage of asbestos plaintiffs	'	'	'
Sale of goods containing asbestos from 1948 to 1958	$40,000,000	'	'
Approximate plaintiffs and claimants (in number of litigants)	2,500	'	'
Approximate number of claims disposed of to date	393,000	'	'
Average indemnity payment per claim	8,700	'	'
Deferred amounts payable	24,000,000	12,000,000	'
Asbestos-related liability, total amount accrued beginning in 1993 through 2013 before insurance recoveries	'	4,300,000,000	975,000,000
Additional estimated period that result in an annual charge, if future comprehensive review of asbestos-related liabilities is not determined	'1 year	'	'
Asbestos related charges	'	145,000,000	'
Damages unspecified or sufficient to invoke jurisdictional minimum	'	'	'
Percentage of asbestos plaintiffs	'	'	'
Percentage of asbestos plaintiffs, approximate percentage	80.00%	'	'
Damages of $15 million or less	'	'	'
Percentage of asbestos plaintiffs	'	'	'
Percentage of asbestos plaintiffs, approximate percentage	16.00%	'	'
Damages greater than $15 million but less than $100 million	'	'	'
Percentage of asbestos plaintiffs	'	'	'
Percentage of asbestos plaintiffs, approximate percentage	3.00%	'	'
Damages equal to or greater than $100 million | OI Inc.	'	'	'
Percentage of asbestos plaintiffs	'	'	'
Percentage of asbestos plaintiffs, fewer than percentage	1.00%	'	'
Non-income tax assessment	'	'	'
Percentage of asbestos plaintiffs	'	'	'
Estimated amount of income-tax assessment including penalties and interest	90,000,000	'	'
Period over which deposit amount of tax assessment will be remitted in monthly installments	'15 months	'	'
Charge created due to unfavorable ruling	60,000,000	'	'
Non-income tax refund	30,000,000	'	'
Installment payments made	$60,000,000	'	'

Share_Owners_Equity_Details

Share Owners' Equity (Details) (USD $)

3 Months Ended

3 Months Ended

In Millions, except Share data, unless otherwise specified

Mar. 31, 2014

Mar. 31, 2013

Dec. 31, 2013

Mar. 31, 2014

Dec. 31, 2013

Mar. 31, 2013

Dec. 31, 2012

Mar. 31, 2014

Mar. 31, 2013

Mar. 31, 2014

Mar. 31, 2013

Mar. 31, 2014

Mar. 31, 2013

Mar. 31, 2014

Mar. 31, 2013

Mar. 31, 2014

Mar. 31, 2013

Common Stock

Common Stock

Common Stock

Common Stock

Capital in Excess of Par Value

Capital in Excess of Par Value

Treasury Stock

Treasury Stock

Retained Earnings (Loss)

Retained Earnings (Loss)

Accumulated Other Comprehensive Loss

Accumulated Other Comprehensive Loss

Non-controlling Interests

Non-controlling Interests

Increase (Decrease) in Share Owners' Equity

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Balance

$1,603

$1,055

'

$2

$2

$2

$2

$3,040

$3,005

($454)

($425)

($11)

($195)

($1,121)

($1,506)

$147

$174

Issuance of common stock (155,727 and 315,704 shares for three months ended March 31, 2014 and 2013, respectively)

4

4

'

'

'

'

'

4

4

'

'

'

'

'

'

'

'

Issuance of common stock (in shares)

155,727

315,704

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Reissuance of common stock (48,041 and 40,771 shares for three months ended March 31, 2014 and 2013, respectively)

2

1

'

'

'

'

'

'

'

2

1

'

'

'

'

'

'

Reissuance of common stock (in shares)

48,041

40,771

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Stock compensation

8

4

'

'

'

'

'

8

4

'

'

'

'

'

'

'

'

Comprehensive income:

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Net earnings

106

74

'

'

'

'

'

'

'

'

'

101

69

'

'

5

5

Other comprehensive income (loss)

56

17

'

'

'

'

'

'

'

'

'

'

'

59

21

-3

-4

Distributions to noncontrolling interests

-19

'

'

'

'

'

'

'

'

'

'

'

'

'

'

-19

'

Balance

$1,760

$1,155

'

$2

$2

$2

$2

$3,052

$3,013

($452)

($424)

$90

($126)

($1,062)

($1,485)

$130

$175

Common stock, shares authorized

250,000,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Common stock, par value (in dollars per share)

$0.01

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Shares outstanding

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Shares of common stock issued (including treasury shares)

183,811,000

182,356,000

183,500,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Treasury shares, at cost

18,738,000

17,861,000

18,786,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Accumulated_Other_Comprehensiv2

Accumulated Other Comprehensive Loss (Details) (USD $)	Dec. 31, 2013	Mar. 31, 2013	Mar. 31, 2014	Mar. 31, 2013	Mar. 31, 2014	Mar. 31, 2013	Mar. 31, 2014	Mar. 31, 2013	Mar. 31, 2014	Mar. 31, 2013
In Millions, unless otherwise specified			Net Effect of Exchange Rate Fluctuations	Net Effect of Exchange Rate Fluctuations	Change in Certain Derivative Instruments	Change in Certain Derivative Instruments	Employee Benefit Plans	Employee Benefit Plans	Accumulated Other Comprehensive Loss	Accumulated Other Comprehensive Loss
Increase (Decrease) Accumulated Other Comprehensive Loss, Net of Tax	'	'	'	'	'	'	'	'	'	'
Balance at beginning of the period	($1,121)	($1,485)	$229	$455	($12)	($14)	($1,338)	($1,947)	($1,121)	($1,506)
Change before reclassifications	'	'	35	-28	2	3	'	'	37	-25
Amounts reclassified from accumulated other comprehensive income	'	'	'	'	-1	1	23	37	22	38
Translation effect	'	'	'	'	'	'	1	10	1	10
Tax effect	'	'	'	'	'	'	-1	-2	-1	-2
Other comprehensive income attributable to the Company	'	'	35	-28	1	4	23	45	59	21
Balance at end of the period	($1,121)	($1,485)	$264	$427	($11)	($10)	($1,315)	($1,902)	($1,062)	($1,485)

Other_Expense_Details

Other Expense (Details) (USD $)	3 Months Ended
In Millions, unless otherwise specified	Mar. 31, 2013
Other Expense	'
Restructuring, asset impairment and related charges	$10

Earnings_Per_Share_Details

Earnings Per Share (Details) (USD $)	3 Months Ended
In Millions, except Share data, unless otherwise specified	Mar. 31, 2014	Mar. 31, 2013
Numerator:	'	'
Net earnings attributable to the Company	$101	$69
Denominator (in thousands):	'	'
Denominator for basic earnings per share - weighted average shares outstanding (in shares)	164,760,000	164,069,000
Effect of dilutive securities:	'	'
Stock options and other (in shares)	1,405,000	1,432,000
Denominator for diluted earnings per share - adjusted weighted average shares outstanding (in shares)	166,165,000	165,501,000
Basic earnings per share:	'	'
Earnings from continuing operations (in dollars per share)	$0.62	$0.48
Loss from discontinued operations (in dollars per share)	($0.01)	($0.06)
Net earnings	$0.61	$0.42
Diluted earnings per share:	'	'
Earnings from continuing operations (in dollars per share)	$0.62	$0.48
Loss from discontinued operations (in dollars per share)	($0.01)	($0.06)
Net earnings	$0.61	$0.42
Weighted average shares of common stock attributable to options not included in diluted earnings per share (in shares)	370,012	1,640,504
Exchange price of 2015 exchangeable notes (in dollars per share)	$47.47	$47.47

Supplemental_Cash_Flow_Informa2

Supplemental Cash Flow Information (Details) (USD $)	3 Months Ended
In Millions, unless otherwise specified	Mar. 31, 2014	Mar. 31, 2013
Supplemental Cash Flow Information	'	'
Interest paid in cash	$70	$81
Income taxes paid in cash (non-U.S.)	31	33
Senior Notes 6.875%, due 2017 (300 million EUR)	'	'
Debt Instrument	'	'
Interest paid note repurchase premiums	'	$9
Interest rate, stated percentage	6.88%	6.88%

Discontinued_Operations_Detail

Discontinued Operations (Details) (USD $)	3 Months Ended
In Millions, unless otherwise specified	Mar. 31, 2014	Mar. 31, 2013
Subsidiaries	'	'
Loss from discontinued operations	$1	$10
Special termination benefits	'	8
Discontinued Operations, Disposed Venezuelan Subsidiaries	'	'
Subsidiaries	'	'
Ongoing costs related to the expropriation	$1	$2

Financial_Information_for_Subs2

Financial Information for Subsidiary Guarantors and Non-Guarantors (Details) (USD $)	3 Months Ended
In Millions, unless otherwise specified	Mar. 31, 2014	Dec. 31, 2013	Mar. 31, 2013
	item
Financial Information for Subsidiary Guarantors and Non-Guarantors	'	'	'
Number of subsidiaries that have guaranteed the notes	2	'	'
Ownership percentage in Guarantor Subsidiaries	100.00%	'	'
Current assets:	'	'	'
Cash and cash equivalents	$201	$383	$359
Receivables	1,078	943	1,047
Inventories	1,204	1,117	1,178
Prepaid expenses	94	107	99
Total current assets	2,577	2,550	2,683
Property, plant and equipment, net	2,634	2,632	2,680
Goodwill	2,059	2,059	2,048
Other assets	1,218	1,178	1,106
Total assets	8,488	8,419	8,517
Current liabilities:	'	'	'
Short-term loans and long-term debt due within one year	331	322	347
Current portion of asbestos liability	150	150	155
Accounts payable	1,074	1,144	904
Other liabilities	527	638	523
Total current liabilities	2,082	2,254	1,929
Long-term debt	3,371	3,245	3,550
Asbestos-related liabilities	283	298	289
Other long-term liabilities	992	1,019	1,594
Share owners' equity	1,760	1,603	1,155
Total liabilities and share owners' equity	8,488	8,419	8,517
Parent	'	'	'
Current assets:	'	'	'
Investments in and advances to subsidiaries	2,313	2,154	1,674
Total assets	2,313	2,154	1,674
Current liabilities:	'	'	'
Current portion of asbestos liability	150	150	155
Total current liabilities	150	150	155
Long-term debt	250	250	250
Asbestos-related liabilities	283	298	289
Share owners' equity	1,630	1,456	980
Total liabilities and share owners' equity	2,313	2,154	1,674
Guarantor Subsidiaries	'	'	'
Current assets:	'	'	'
Investments in and advances to subsidiaries	2,063	1,904	1,424
Total assets	2,063	1,904	1,424
Current liabilities:	'	'	'
Share owners' equity	2,063	1,904	1,424
Total liabilities and share owners' equity	2,063	1,904	1,424
Non-Guarantor Subsidiaries	'	'	'
Current assets:	'	'	'
Cash and cash equivalents	201	383	359
Receivables	1,078	943	1,047
Inventories	1,204	1,117	1,178
Prepaid expenses	94	107	99
Total current assets	2,577	2,550	2,683
Property, plant and equipment, net	2,634	2,632	2,680
Goodwill	2,059	2,059	2,048
Other assets	1,218	1,178	1,106
Total assets	8,488	8,419	8,517
Current liabilities:	'	'	'
Short-term loans and long-term debt due within one year	331	322	347
Accounts payable	1,074	1,144	904
Other liabilities	527	638	523
Total current liabilities	1,932	2,104	1,774
Long-term debt	3,371	3,245	3,550
Other long-term liabilities	992	1,019	1,594
Share owners' equity	2,193	2,051	1,599
Total liabilities and share owners' equity	8,488	8,419	8,517
Eliminations	'	'	'
Current assets:	'	'	'
Investments in and advances to subsidiaries	-4,376	-4,058	-3,098
Total assets	-4,376	-4,058	-3,098
Current liabilities:	'	'	'
Long-term debt	-250	-250	-250
Share owners' equity	-4,126	-3,808	-2,848
Total liabilities and share owners' equity	($4,376)	($4,058)	($3,098)

Financial_Information_for_Subs3

Financial Information for Subsidiary Guarantors and Non-Guarantors (Details 2) (USD $)	3 Months Ended
In Millions, unless otherwise specified	Mar. 31, 2014	Mar. 31, 2013
Results of Operations	'	'
Net sales	$1,639	$1,641
Cost of goods sold	-1,318	-1,322
Gross profit	321	319
Selling and administrative expense	-133	-129
Research, development and engineering expense	-15	-15
Interest expense, net	-54	-68
Other equity earnings	16	17
Other expense, net	-1	-7
Earnings from continuing operations before income taxes	134	117
Provision for income taxes	-27	-33
Earnings from continuing operations	107	84
Loss from discontinued operations	-1	-10
Net earnings	106	74
Net earnings attributable to noncontrolling interests	-5	-5
Net earnings attributable to the Company	101	69
Comprehensive Income	'	'
Net earnings	106	74
Other comprehensive income, net	56	17
Total comprehensive income	162	91
Comprehensive income attributable to noncontrolling interests	-2	-1
Comprehensive income attributable to the Company	160	90
Cash Flows	'	'
Cash utilized in operating activities	-203	-136
Cash utilized in investing activities	-95	-94
Cash provided by financing activities	122	159
Effect of exchange rate change on cash	-6	-1
Decrease in cash	-182	-72
Cash at beginning of period	383	431
Cash at end of period	201	359
Parent	'	'
Results of Operations	'	'
Net intercompany interest	5	5
Interest expense, net	-5	-5
Equity earnings from subsidiaries	101	69
Earnings from continuing operations before income taxes	101	69
Earnings from continuing operations	101	69
Net earnings	101	69
Net earnings attributable to the Company	101	69
Comprehensive Income	'	'
Net earnings	101	69
Other comprehensive income, net	59	21
Total comprehensive income	160	90
Comprehensive income attributable to the Company	160	90
Cash Flows	'	'
Cash utilized in operating activities	-15	-17
Cash provided by financing activities	15	17
Guarantor Subsidiaries	'	'
Results of Operations	'	'
Equity earnings from subsidiaries	101	69
Earnings from continuing operations before income taxes	101	69
Earnings from continuing operations	101	69
Net earnings	101	69
Net earnings attributable to the Company	101	69
Comprehensive Income	'	'
Net earnings	101	69
Other comprehensive income, net	59	21
Total comprehensive income	160	90
Comprehensive income attributable to the Company	160	90
Non-Guarantor Subsidiaries	'	'
Results of Operations	'	'
Net sales	1,639	1,641
Cost of goods sold	-1,318	-1,322
Gross profit	321	319
Selling and administrative expense	-133	-129
Research, development and engineering expense	-15	-15
Net intercompany interest	-5	-5
Interest expense, net	-49	-63
Other equity earnings	16	17
Other expense, net	-1	-7
Earnings from continuing operations before income taxes	134	117
Provision for income taxes	-27	-33
Earnings from continuing operations	107	84
Loss from discontinued operations	-1	-10
Net earnings	106	74
Net earnings attributable to noncontrolling interests	-5	-5
Net earnings attributable to the Company	101	69
Comprehensive Income	'	'
Net earnings	106	74
Other comprehensive income, net	37	-12
Total comprehensive income	143	62
Comprehensive income attributable to noncontrolling interests	-2	-1
Comprehensive income attributable to the Company	141	61
Cash Flows	'	'
Cash utilized in operating activities	-188	-119
Cash utilized in investing activities	-95	-94
Cash provided by financing activities	107	142
Effect of exchange rate change on cash	-6	-1
Decrease in cash	-182	-72
Cash at beginning of period	383	431
Cash at end of period	201	359
Eliminations	'	'
Results of Operations	'	'
Equity earnings from subsidiaries	-202	-138
Earnings from continuing operations before income taxes	-202	-138
Earnings from continuing operations	-202	-138
Net earnings	-202	-138
Net earnings attributable to the Company	-202	-138
Comprehensive Income	'	'
Net earnings	-202	-138
Other comprehensive income, net	-99	-13
Total comprehensive income	-301	-151
Comprehensive income attributable to the Company	($301)	($151)